These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38268359)

  • 21. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring.
    Bayaa R; Ndiaye MDB; Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Nasrin R; Ranaivomanana P; Raherinandrasana AH; Rakotonirina J; Rasolofo V; Delogu G; De Maio F; Goletti D; Endtz H; Ader F; Hamze M; Ismail MB; Pouzol S; Rakotosamimanana N; Hoffmann J;
    Sci Rep; 2021 Jul; 11(1):13646. PubMed ID: 34211042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Latent M. tuberculosis infection, update 2011].
    Lechartier B; Mazza-Stalder J; Janssens JP; Nicod LP
    Rev Med Suisse; 2011 Nov; 7(318):2289-94. PubMed ID: 22400364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The journey from latent to active TB: no roadmaps as yet.
    Khurana AK; Khurana U
    Chest; 2012 Sep; 142(3):811. PubMed ID: 22948596
    [No Abstract]   [Full Text] [Related]  

  • 24. A promising test to distinguish between active tuberculosis and latent tuberculosis.
    Jolobe OM
    QJM; 2015 Jun; 108(6):515. PubMed ID: 25638781
    [No Abstract]   [Full Text] [Related]  

  • 25. Experiences in implementation of routine human immunodeficiency virus testing in a US tuberculosis clinic.
    Gardner A; Naureckas C; Beckwith C; Losikoff P; Martin C; Carter EJ
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1241-6. PubMed ID: 22793872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response.
    Diel R
    Chest; 2013 May; 143(5):1515-1516. PubMed ID: 23648926
    [No Abstract]   [Full Text] [Related]  

  • 27. Standard operating procedures for tuberculosis care.
    Solovic I; Abubakar I; Sotgiu G; Dara M; Goletti D; Duarte R; Aliberti S; de Benedictis FM; Ward B; Teixeira V; Gratziou C; Migliori GB
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28572129
    [No Abstract]   [Full Text] [Related]  

  • 28. Tuberculosis prevention and control in prisons: do we know enough?
    Dara M; Acosta CD
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):758-9. PubMed ID: 24902546
    [No Abstract]   [Full Text] [Related]  

  • 29. Multifocal Osteoarticular Tuberculosis in a Lupus With Sjogren Syndrome Patient.
    Reyes HA; Ruiz MA; Sy AM; Boma N; Kadeishvili K
    Am J Ther; 2017; 24(4):e498-e499. PubMed ID: 27574932
    [No Abstract]   [Full Text] [Related]  

  • 30. Global stability in a tuberculosis model of imperfect treatment with age-dependent latency and relapse.
    Ren S
    Math Biosci Eng; 2017 Oct/Dec 1; 14(5-6):1337-1360. PubMed ID: 29161864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis].
    Bergot E; Abiteboul D; Andréjak C; Antoun F; Barras E; Blanc FX; Bourgarit A; Charlois-Ou C; Delacourt C; Dirou S; Gerin M; Guerin S; Haustraete É; Henry B; Lucet JC; Maitre T; Morin J; Le Palud P; Pommelet V; Rivoisy C; Robert J; Veziris N; Herrmann JL
    Rev Mal Respir; 2018 Oct; 35(8):852-858. PubMed ID: 30224215
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interferon gamma release assay tests for the diagnosis of latent and active tuberculosis in hemodialysis patients or solid organ transplant recipients].
    Henry B; Bourgarit A
    Rev Mal Respir; 2018 Oct; 35(8):890-893. PubMed ID: 30268409
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for Latent Tuberculosis Infection in Patients who are Candidate for Biological Therapies in Spain? A Multidisciplinary Survey.
    Quirós S; de la Rosa D; Uranga A; Madero R; Amaro R; Bruguera N; García JA; Gómez C; Iturbe D; Lera R; Luque L; Martínez AJ; Mínguez P; Navarro A; Sánchez G; Suárez-Cuartín G
    Arch Bronconeumol (Engl Ed); 2018 Oct; 54(10):510-517. PubMed ID: 29941293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latent Tuberculosis Infection Treatment: Still a Long Road Ahead.
    Louie JK; Keh CE
    Clin Infect Dis; 2023 Jul; 77(2):295-297. PubMed ID: 37125504
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fallacies of Mantoux in the Diagnosis of Latent Tuberculosis.
    Tandon A; Tandon S
    J Assoc Physicians India; 2022 Dec; 70(12):11-12. PubMed ID: 37355981
    [No Abstract]   [Full Text] [Related]  

  • 37. New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets?
    Ruhwald M; Andersen PL
    Future Microbiol; 2016 Sep; 11():1101-4. PubMed ID: 27545599
    [No Abstract]   [Full Text] [Related]  

  • 38. QuantiFERON-TB Gold+ for the Diagnosis of Mycobacterium tuberculosis Infection.
    Yancey JR; Melchert VE
    Am Fam Physician; 2021 Feb; 103(3):177-178. PubMed ID: 33507050
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of insurance claims and electronic health records to assess tuberculosis and latent tuberculosis diagnosis.
    Rossato Silva D; van den Hof S
    Int J Tuberc Lung Dis; 2020 Jul; 24(7):659-660. PubMed ID: 32718396
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycobacterial Disease: Evolving Concepts.
    Flume PA; Winthrop KL
    Semin Respir Crit Care Med; 2018 Jun; 39(3):269. PubMed ID: 30071542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.